UK
450,000 missed breast cancer screenings, 270 lives potentially shortened
May 2, 2018Medical Communications Jeremy Hunt, NHS, UK, biotech, drugs, pharma, pharmaceutical
An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s …
UK media coverage vastly underrepresents older cancer patients and their risk, study finds
April 26, 2018Medical Communications, Research and Development Cancer, Cancer Research UK, UK, University of Glasgow, pharma
A Cancer Research UK-funded study undertaken by the University of Glasgow has revealed that representation and coverage of cancer patients …
May announces £75m prostate cancer boost
April 10, 2018Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer
Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …
Almost 40% of UK prostate cancer cases are diagnosed late, according to report
April 9, 2018Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer
A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …
Takeda move for Shire looks increasingly likely
April 6, 2018Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical
Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …
Obesity admissions double in four years
April 5, 2018Medical Communications NHS, UK, biotech, drugs, pharma, pharmaceutical
New figures show that hospital admissions related to obesity have doubled over the last four years in the UK, placing …
Independent committee report seeks Brexit healthcare clarity
March 21, 2018Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical
An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
Hammond suggests NHS may receive cash boost
March 14, 2018Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical
The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …
UK Government to offer HPV vaccine to men who have sex with men
February 6, 2018Manufacturing and Production, Medical Communications, Research and Development England, HPV, UK, human papillomavirus, pharma, vaccination
The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …
UK GPs are “undervalued” with 40% looking to quit profession, study finds
February 5, 2018Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma
Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …
Faslodex rejected by NICE for NHS breast cancer use
February 2, 2018Research and Development, Sales and Marketing AstraZeneca, Faslodex, NHS, NICE, UK, pharma
Bad news for breast cancer patients in the UK as the National Institute for Health and Care Excellence announces it …
UK charity Breast Cancer Care receives £655,000 cash injection to expand end-of-treatment app
January 31, 2018Research and Development Breast Cancer Care, National lottery, UK, breast cancer, charity, pharma
UK charity Breast Cancer Care (BCC) is set to expand the development of its end-of-treatment support app after receiving a …
Read Pharmafocus January/February 2018 edition online now!
January 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Ablynx, Alex Azr, Celgene, Pharmafocus, Sanofi, UK, artificial intelligence, bioverativ, brexit, juno therapeutics, multiple myeloma, serialisation
With the holiday period a distant memory by now, Pharmafocus is back with its January/febraury edition. It’s hard to imagine …
20,000 left disabled in UK due to sodium valproate use during pregnancy
January 22, 2018Medical Communications, Sales and Marketing Epilim, Sanofi, Sodium valproate, UK, pharma
Liberal Democrat MP Norman Lamb has drawn attention to what he has called an “extraordinary scandal” in which an estimated …
Pfizer’s Xalkori sees rejection at the hands of NICE in lung cancer
January 19, 2018Medical Communications, Sales and Marketing Cancer, NCIE, NSCLC, Pfizer, UK, Xalkori, lung cancer, pharma
UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
